Mainz Biomed, Quest Diagnostics To Commercialize NextGen Colorectal Cancer Screening Test; Stock Up
(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...